Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2016-01-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于公司部分固定资产报废处理的公告
Regulatory Filings Classification · 95% confidence The document is titled as an announcement regarding the disposal of certain fixed assets by the company. It details the board meeting decision to scrap outdated and unsafe fixed assets, including the financial impact on the company's 2015 profits. The document includes opinions from independent directors and the supervisory board endorsing the asset disposal. The content is a formal announcement of a specific corporate action (fixed asset disposal) rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The document length is short (1208 characters), and it is clearly an announcement of a corporate event rather than a report or filing of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-01-29 Chinese
2015年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" which translates to "Audit Report" for the fiscal year 2015. It includes detailed auditor statements, responsibilities of management and auditors, and an explicit audit opinion. The document contains comprehensive financial statements such as consolidated and parent company balance sheets, income statements, cash flow statements, and notes to the financial statements. The presence of the auditor's signature and certification further confirms this is a standalone audit report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the category of an Audit Report / Information (AR). FY 2015
2016-01-29 Chinese
2015年度控股股东及其他关联方资金占用情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized statement regarding the use of funds by controlling shareholders and related parties for the fiscal year 2015 of 三诺生物传感股份有限公司. It is prepared by a certified public accounting firm and references the audited financial statements for the year ended December 31, 2015. The document includes a detailed summary table of fund occupation by related parties and is intended to comply with regulatory disclosure requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is not a full annual report but a standalone audit-related disclosure focusing on related party transactions and fund occupation. It contains audit verification and certification but does not present the full financial statements or comprehensive annual report content. Therefore, it fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related disclosure about specific financial matters, not the full annual report or a simple announcement. FY 2015
2016-01-29 Chinese
2015年度独立董事（唐红女士）述职报告
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of the company summarizing their duties, attendance at board and shareholder meetings, independent opinions on various company matters, committee work, on-site inspections, and efforts to protect investor rights for the year 2015. It includes specific dates and references to company governance activities and financial oversight but does not contain full financial statements or quarterly results. It is a formal report on the director's activities and opinions rather than a general annual report or earnings release. This fits best under Board/Management Information (MANG), which covers announcements related to board members and their roles.
2016-01-29 Chinese
2015年度独立董事（李永国先生）述职报告
Board/Management Information Classification · 95% confidence The document is a detailed 2015 annual report by an independent director of the company, describing attendance at board and shareholder meetings, independent opinions on various board resolutions, committee work, on-site inspections, shareholder rights protection, and training activities. It is a formal report on the independent director's duties and activities during the year, not an announcement or a brief summary. The content focuses on governance and oversight activities rather than financial results or audit opinions alone. This fits best with the category of Board/Management Information (MANG), which covers announcements related to board members and their activities. The document length is 3760 characters, which is sufficient for a detailed report but not a full annual report or audit report. It is not a certification or a regulatory filing. Therefore, the classification is MANG with high confidence.
2016-01-29 Chinese
中信证券股份有限公司关于公司2015年度募集资金存放与使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring institution (中信证券股份有限公司) regarding the 2015 annual verification of the storage and use of raised funds by 三诺生物传感股份有限公司. It includes detailed financial figures about the amount raised, usage, interest income, and balances, as well as compliance with regulatory requirements and internal controls. The document references specific regulatory guidelines and includes an auditor's verification opinion on the use of the raised funds. This type of document is a specialized audit or verification report focused on the use of capital raised through public offerings, rather than a full annual report or earnings release. It is not a general financial report but a standalone audit/verification report on fundraising usage and compliance. Therefore, it fits best under the category Audit Report / Information (AR). The document length and detail confirm it is the report itself, not just an announcement or certification letter. FY 2015
2016-01-29 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.